Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic protein discovery using proteolytic peptide targeting and identification.

John M Koomen1, Haitao Zhao, Donghui Li

  • 1Molecular Pathology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

Rapid Communications in Mass Spectrometry : RCM
|October 7, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasmonic Re-Excitation Enables Superoxide-Mediated Ethane Conversion to Acetic Acid under Visible Light.

Journal of the American Chemical Society·2026
Same author

Integrative machine learning and experimental validation reveal the molecular mechanisms of 2-bromo-4,6-dinitroaniline nephrotoxicity: CD45 and cyclophilin C as early response biomarkers of renal tubular injury.

Toxicology and applied pharmacology·2026
Same author

Interacting and joint effects of frailty and depressive symptoms in relation to risk of cardio-oncology comorbidity in older adults from three prospective cohorts.

BMC geriatrics·2026
Same author

Addressing phase instability and charge recombination in pyrolysis-synthesized BiVO<sub>4</sub> via DFT-guided Mo doping for enhanced performance.

National science review·2026
Same author

Denitrification vs. assimilation: shifting metabolic pathways to enable N recovery from low-strength municipal wastewater.

Bioresource technology·2026
Same author

Unlocking the Solution Processability of Graphene Nanoribbons via a Solvent-Assisted Direct Fluorination.

ACS applied materials & interfaces·2026

This study introduces an improved method for cancer diagnostics using peptide profiling and mass spectrometry, enhancing sensitivity and protein identification for disease biomarker discovery.

Area of Science:

  • Biomarker Discovery
  • Proteomics
  • Mass Spectrometry

Background:

  • Plasma protein profiling using mass spectrometry is under investigation for disease diagnostics.
  • Current methods using intact protein analysis with MALDI-TOFMS face limitations in sensitivity, mass range, and protein identification.
  • Challenges exist in validating diagnostic fingerprints derived from intact protein profiles.

Purpose of the Study:

  • To present an alternative and improved method for diagnostic protein discovery.
  • To enhance sensitivity and expand the accessible protein molecular weight range for diagnostics.
  • To validate diagnostic biomarkers through peptide sequencing.

Main Methods:

  • Proteolytic peptide profiling using enzymatic digestion (trypsin) of plasma protein fractions.

Related Experiment Videos

  • Bioinformatic targeting of ion signals based on disease-specific peak intensity ratios and t-tests.
  • Peptide identification using MALDI tandem mass spectrometry (MS/MS) on quadrupole-TOF and tandem-TOF instruments.

    • Main Results:

    • The method successfully identified proteins previously found and detected additional proteins.
    • Peptide profiling improved sensitivity and extended the detectable protein molecular weight range compared to intact protein profiling.
    • Initial findings align with the known biology of pancreatic cancer and pancreatitis but lack disease specificity.

    Conclusions:

    • Proteolytic peptide profiling coupled with targeted MS/MS analysis offers an improved approach for diagnostic biomarker discovery.
    • This method overcomes limitations of intact protein profiling in sensitivity and mass range.
    • Further research is needed to achieve disease-specific diagnostic signatures.